Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT05107180
Other study ID # succide among drug addict
Secondary ID
Status Not yet recruiting
Phase
First received
Last updated
Start date December 2021
Est. completion date December 2023

Study information

Verified date October 2021
Source Assiut University
Contact hebat allah hassan goda
Phone 01090200687
Email hebagoda119@gmail.com
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

detect risk of suicide among patient with substance use disorder


Description:

Substance use disorder (or drug addiction) is a neuropsychiatric disorder characterized by recurring desire to continue taking the drug despite harmful consequences. Substance use disorders are a major risk factor for suicide Suicide is a leading cause of premature death in young adults. Data from the World Health Organization indicate that the rate of completed suicide for the world's population is 16 per 100,000 inhabitants, which means that each year more than a million people in the world commit suicide. Suicide attempts are five to twenty times more common than the completed suicide.Based on the data from the research community, approximately 5% of adults attempts suicide at least once in their lifetime . Mental health problems are the most common and best explored risk factor associated suicidal ideas, suicide attempts and completed suicide. About 90% of all people who commit suicide met the diagnostic criteria for one or more psychiatric disorders . People who use alcohol and/or drugs or are dependent on them, attempting suicide nearly six times more often than people who do not use these substances. The rate of completed suicide among addicts is 2 to 3 times higher than among the males who are not addictst, while in a few cases the manner in which the suicide is attempted is not directly related to drugs . Although there is a correlation between the disorder caused by the use of substances and suicidal behavior, a large number of addicts will never attempt suicide. It is therefore important to identify those individuals with the disorder caused by the use of substances that may be at higher risk for suicide . Many risk factors for suicide in the general population also apply to drug addicts. The older drug addicts are at higher risk for attempts and suicides than younger addicts Another very important fact when it comes to suicide attempts is the drug used. It is known that heroin and sedatives are substances with which suicide attempts suicide are most often made, while other drugs are less characteristic .


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 100
Est. completion date December 2023
Est. primary completion date December 2021
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 70 Years
Eligibility Inclusion Criteria: - Patients fulfilling diagnostic criteria of substance use disorder 1. social impairment 2. impaired control 3. risky use 4. pharmacological indicators (tolerance and withdrawal). Exclusion Criteria: - Patient with other psychatric disorders ex schizophrenia, mood disorder

Study Design


Related Conditions & MeSH terms


Intervention

Diagnostic Test:
drug screen
urine sample

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Assiut University

References & Publications (2)

Webster LR. Risk Factors for Opioid-Use Disorder and Overdose. Anesth Analg. 2017 Nov;125(5):1741-1748. doi: 10.1213/ANE.0000000000002496. Review. — View Citation

Yuodelis-Flores C, Ries RK. Addiction and suicide: A review. Am J Addict. 2015 Mar;24(2):98-104. doi: 10.1111/ajad.12185. Epub 2015 Feb 2. Review. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Prevelance of suicide and suicide tendancy in patients with substance use disorders. observation and study of prevelance of suicide among patient with substance use disorders 6 months
Primary Detect risk factors for suicide and in patients with substance use disorder. observation of patient 6 months
See also
  Status Clinical Trial Phase
Completed NCT05660434 - Using Aromatherapy in Substance Use Disorder N/A
Active, not recruiting NCT05338268 - Substance Use and Loneliness N/A
Completed NCT04098614 - Barriers to Substance Use Disorder Recovery N/A
Completed NCT03954184 - E-health Implementation (Iowa) N/A
Completed NCT03590106 - Cardiac Surgery Peer Recovery Support Program N/A
Recruiting NCT05118204 - Randomized Trial of Buprenorphine Microdose Inductions During Hospitalization Phase 4
Recruiting NCT06273228 - Parenting Young Children in Pediatrics N/A
Recruiting NCT05327504 - Written Exposure Therapy for Veterans With SUD and PTSD N/A
Terminated NCT03517111 - The Impact of a Parenting Intervention on Latino Youth Health Behaviors N/A
Completed NCT04284813 - Families With Substance Use and Psychosis: A Pilot Study N/A
Completed NCT04401215 - Technologically-Augmented Referrals to Mitigate Addiction Consequences N/A
Not yet recruiting NCT06163651 - Evaluating a One-Year Version of the Parent-Child Assistance Program N/A
Not yet recruiting NCT06187701 - Co-Active Therapeutic Theatre (Co-ATT) for Dual-Diagnosis Patients N/A
Recruiting NCT04296604 - Transcranial Direct Current Stimulation (tDCS) Neuromodulation of Executive Function Across Neuropsychiatric Populations N/A
Active, not recruiting NCT02382042 - Intensive Referral Intervention to Improve Substance Use Disorder Treatment Outcomes Among Rural and Highly Rural Veterans N/A
Completed NCT01237366 - Study Targeting Affect Regulation Phase 1/Phase 2
Terminated NCT01356667 - Drum-Assisted Therapy for Native Americans N/A
Completed NCT00708890 - Twelve Step Based Self-help Groups for Substance Related Disorders N/A
Active, not recruiting NCT04048850 - Zepatier in Patients With Substance Use
Recruiting NCT05976646 - Phase Ib/2a Drug-drug Interaction Study of a Combination of 45mg Dextromethorphan With 105 mg Bupropion Phase 1/Phase 2